Anticorps Recombinant de lapin anti-G3BP2

G3BP2 Recombinant Antibody for WB, IHC, IF/ICC, FC (Intra), Cytometric bead array, Sandwich ELISA, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, IHC, IF/ICC, FC (Intra), Cytometric bead array, Sandwich ELISA, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

230275D6

N° de cat : 82080-4-PBS

Synonymes

G3BP 2, 230275D6, G3BP-2, GAP SH3 domain binding protein 2, GAP SH3 domain-binding protein 2



Informations sur le produit

82080-4-PBS cible G3BP2 dans les applications de WB, IHC, IF/ICC, FC (Intra), Cytometric bead array, Sandwich ELISA, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène G3BP2 Protéine recombinante Ag9355
Nom complet GTPase activating protein (SH3 domain) binding protein 2
Masse moléculaire calculée482aa,54 kDa; 449aa,51 kDa
Poids moléculaire observé65-70 kDa
Numéro d’acquisition GenBankBC011731
Symbole du gène G3BP2
Identification du gène (NCBI) 9908
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Stress granules (SGs) are cytoplasmic mRNA-protein condensates formed in response to cellular stressors, such as oxidative stress, ultraviolet radiation, and viral infection (1). The Ras-GTPase-activating protein-binding proteins (G3BPs), consisting of G3BP1 and G3BP2, are key nucleating factors essential for SG formation. They function to protect RNAs from harmful conditions. G3BP2 is mainly distributed in the cytoplasm and participates in the formation of stress granules, cell differentiation, proliferation, and signal transduction. Accumulating evidence has demonstrated that aberrant expression of G3BP2 contributes to cancer initiation and progression, such as high expression of G3BP2 increasing cell stemness, metastasis and chemoresistance in breast cancer.

{{ptg:RelatedPrimaryAntibodies}}